For well over a year, pharmacists, physicians and patients have been anticipating the possibility of a shortage of immune globulin (IG) products, as the COVID-19 pandemic led to a significant decline in donations of the blood plasma that is the primary component of these therapies.
According to the Plasma Protein Therapeutics Association, plasma donations fell by 20% in 2020. Because the fractionation process that turns donated plasma into IG can take nine to 12 months from